All episodes

Idarucizumab is a monoclonal antibody fragment with high affinity for dabigatran reversing its anticoagulant effects within minutes. Patients with acute ischemic stroke on dabigatr...

Mobile stroke units, otherwise known as MSUs have recently been introduced in the care of patients suspected of having an acute stroke, leading to shortening in the time to thrombo...

Anecdotal reports and clinical observations have recently emerged suggesting a relationship between COVID-19 disease and stroke; highlighting the possibility that infected individu...

Clinical assessment scores in acute ischemic stroke are only moderately correlated with lesion volume since lesion location is an important confounding factor. Many studies have in...

In health research we often hear, and pay lip service to the term ‘patient centred‘. Many of us would probably be hard pressed to devise entirely patient centred studies. "Take Cha...

Controversy and great interest exists regarding cardiovascular and cerebrovascular risk and it’s relationship to sleep duration. Carmen Lahiff-Jenkins, Managing Editor of the Inter...

The thrombolysis in cerebral infarction scale otherwise known as the (TICI) scale is an important outcome measure to evaluate the quality of endovascular stroke therapy. The TICI s...

Coronavirus disease 2019 (COVID-19) is an ongoing pandemic characterized by high morbidity and mortality. Clinical factors that can identify patients at risk for worse outcomes can...

On March 11th, 2020 the World Health Organization declared the COVID-19 infection a pandemic. We are currently in the throws of that global infection and the big question everyone ...

Obstructive sleep apnea is common among patients with acute ischemic stroke and is associated with reduced functional recovery and an increased risk for recurrent vascular events. ...

Thank you for listening to our podcast produced by the International Journal of Stroke! To help us spread the word please share with your colleagues, on twitter and if you are feel...

In 2017, for the first time, stroke, became the second most common cause of both death and disability in the world.  In New Zealand (NZ) the situation is even more dire as was prev...

Informal caregivers in stroke: life impact, support and psychological well-being - a Swedish Stroke Register (Riksstroke) study In 2016, the Swedish Stroke Register, Riksstroke, co...

In this podcast World Stroke Organization members from Japan demonstrate the importance of professional and patient collaboration in influencing stroke policy. We spoke to people f...

In 2015 discussions began among key researchers in the field of stroke rehabilitation and recovery. This resulted in the Stroke Recovery and Rehabilitation Roundtable who met in Ph...

In 2015 discussions began among key researchers in the field of stroke rehabilitation and recovery. This resulted in the Stroke Recovery and Rehabilitation Roundtable who met in Ph...

In 2015 discussions began among key researchers in the field of stroke rehabilitation and recovery.  This resulted in the Stroke Recovery and Rehabilitation Roundtable who met in P...

In 2015 discussions began among key researchers in the field of stroke rehabilitation and recovery.  This resulted in the Stroke Recovery and Rehabilitation Roundtable who met in P...

Dr George Ntaois on 'Oral anticoagulation versus antiplatelet/placebo for stroke prevention in patients with heart failure and sinus rhythm: systematic review and meta-analysis of ...

Older Episodes »

Podbean App

Play this podcast on Podbean App